TOPICS

Tag: biologics

The Psoriasis Decision Tree

J Clin Aesthet Dermatol. 2021;14(4):14–22. by George Monks, MD; Ryan Rivera-Oyola, MS; Mark Lebwohl, MD Dr. Monks is with the Department of Dermatology, University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. Mr. Rovera-Oyola and Dr. Lebwohl are with the Department of Dermatology, Icahn School of Medicine at Mt. Sinai Hospital in New York,

CONTINUE READING »

Updates in Psoriasis Management 2020—Based on Selected Presentations from Maui Derm 2020, January 25–29, 2020, Maui, Hawaii

Updates in Psoriasis Management 2020 Based on Selected Presentations from Maui Derm 2020 January 25–29, 2020, Maui, Hawaii by Jo Ann LeQuang Ms. Lequang is Owner of LeQ Medical in Angleton, Texas; Director of Scientific Communications at NEMA Research, Inc., in Naples, Florida; and Founding Director of No Baby Blisters in Colorado Springs, Colorado. J

CONTINUE READING »

Updates in Psoriasis Management 2019—Based on Selected Presentations from Maui Derm 2019, January 26–30, 2019, Maui, Hawaii

Updates in Psoriasis Management 2019 Based on Selected Presentations from Maui Derm 2019 January 26–30, 2019, Maui, Hawaii by Jo Ann LeQuang Ms. Lequang is Owner of LeQ Medical in Angleton, Texas, Director of Scientific Communications at NEMA Research, Inc., in Naples, Florida, and Founding Director of No Baby Blisters in Colorado Springs, Colorado. J Clin

CONTINUE READING »